Entyvio Side Effects
Generic name: vedolizumab
Important: This document provides details on the Entyvio side effects. Certain dosage forms mentioned in this document might be different and may not apply to the name brand Entyvio.
Summary
Common Entyvio side effects include nasopharyngitis. Other adverse Entyvio side effects include upper respiratory tract infection as well as fatigue. Check out the following list of adverse reactions.
For the Consumer
It is applicable to the drug vedolizumab the powder that is administered intravenously for solution
Medical care
Alongside its necessary benefits, vedolizumab (the active ingredient found within Entyvio) can cause undesirable adverse effects. While some of these adverse effects could occur, if they occur, they could require medical treatment.
Consult your physician or nurse right away if you experience any side effect listed below. happen during the course of taking Entyvio
More popular
- Pain or aches in the body
- chills
- difficulties breathing
- Otis
- The fever
- headache
- Voice loss
- nasal congestion
- runny nose
- Snorting
- Sore throat
- unusual fatigue or weakness
Less popular
Rare
- Cough
- difficulty swallowing
- dizziness
- rapid heartbeat
- Hives itching, skin itching, or rash
- Swelling or puffiness on the eyelids, around the eyelids, face, lips or tongue
- The chest is tight
Incidence unknown
- Stomach or abdominal pain
- blurred vision
- Stools made of clay
- confusion
- convulsions
- Dark urine that is dark
- Drool
- headache
- Appetit loss
- Lower back or side or side
- Urination that is painful or difficult to urinate
- Bad breath smell
- the vomiting of blood
- Yellow eyes or skin
There are no immediate side effects that require medical treatment
A few negative Entyvio side effects could occur, and they typically do not require medical care. These Entyvio side effects could be eliminated after treatment, as your body adapts to medication. Also, your healthcare specialist may provide suggestions on ways to minimize or prevent certain adverse consequences.
Talk to your doctor If any of the following side effects persist or become troubling or if there are any concerns about these side effects:
More popular
- Trouble with moving
- Muscle pain or stiffness
- joint pain
Managing side effects (general information)
For Healthcare Professionals
It is applicable to vedolizumab Intravenous injection of powder
General
- The most frequently reported negative reactions included nasopharyngitis arthritis, headache, nausea, pyrexia lower respiratory tract infections and fatigue. They also experienced cough, bronchitis influenza and back pain. itching, pruritus, oropharyngeal pain, and pain in the extremities
Dermatologic
- Common (1% to 10%): Rash, pruritus, eczema, erythema, night sweats, acne
- Uncommon (0.1% to 1%): Folliculitis ¶
Gastrointestinal
- Common (1 to 10%) Nausea, pain in the oropharynx as well as gastroenteritis, anal abscess dyspepsia, anal fissure constipation, abdominal pain, hemorrhoids, flatulence
Genitourinary
- The frequency of the infection is not reported Urinary tract infection
Hepatic
- Frequency not disclosed: Transaminase elevations and elevations of bilirubin elevations of ALT in hepatitis the elevations of AST
Hypersensitivity
- Common (1 to 10%) Reactions related to infusions (e.g. Infusion site reaction, pain at the infusion site, and irritation to the infusion site)
- Extremely uncommon (less than 1%): Anaphylactic reaction (e.g., dyspnea or bronchospasm urticaria flushing or rash, an increase in blood pressure, a higher heart rate)(e.g., urticaria, dyspnea, flushing more than 0.01%): Anaphylactic reaction
Immunologic
- Common (1 to 10%): Influenza
- Uncommon (0.1 to 1%): Bacterial sepsis Septic shock
Frequency not reported: Sepsis, tuberculosis, salmonella sepsis, Listeria meningitis, giardiasis, cytomegaloviral colitis
Musculoskeletal
- Very frequent (10% plus): Arthralgia (12%)
- Common (1 to 10%): Pain in the back and pain in the extremities.
Nervous system
- Very frequent (10% plus): Headache (12 percent)
- Common (1% to 10%): Paresthesia
Oncologic
- Very rare (less than 0.1 %) Carcinoid tumours of the appendix
- Frequency not disclosed: B-cell lymphoma breast cancer colon cancer malignant hepatic tumor Malignant lung neoplasm malignant melanoma and lung cancer of primary neuroendocrine cancer, the renal cancer, squamous-cell cancer
Other
- Common (1 to 10%): The most common symptoms are fatigue, pyrexia. (1% to 10%)
- Very often (10% or more) Nasopharyngitis (13 percent)
Cardiovascular
- Common (1% to 10%): Hypertension
More details
Always consult your doctor to make sure the information presented on this page is applicable to your specific situation.
Some adverse reactions may not be disclosed. Some side effects may not be reported. You can be able to report them to the FDA.